Gross Profit (TTM) Chart

View Gross Profit (TTM) for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -2.973M
March 31, 2026 -2.986M
September 30, 2025 -2.791M
June 30, 2025 -3.070M
March 31, 2025 -0.5947M
September 30, 2024 -0.8434M
June 30, 2024 -1.303M
March 31, 2024 -1.093M
December 31, 2023 -1.051M
September 30, 2023 -0.8342M
June 30, 2023 -0.6167M
March 31, 2023 -0.6155M
December 31, 2022 -0.6287M
September 30, 2022 -0.6682M
June 30, 2022 -0.7142M
March 31, 2022 -0.7612M
December 31, 2021 -0.792M
September 30, 2021 -0.8148M
June 30, 2021 -0.8303M
March 31, 2021 -0.8152M
December 31, 2020 -0.8134M
Date Value
September 30, 2020 -0.7963M
June 30, 2020 -0.784M
March 31, 2020 -0.8096M
December 31, 2019 -0.7415M
September 30, 2019 -0.6251M
June 30, 2019 -0.4902M
March 31, 2019 -0.3089M
December 31, 2018 -0.2031M
September 30, 2018 -0.1444M
June 30, 2018 -0.118M
March 31, 2018 -0.0846M
December 31, 2017 -0.0576M
September 30, 2017 -0.0364M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
MediGene AG --
BioNTech SE 1.975B
Immatics NV 0.00
Beam Therapeutics, Inc. 133.79M
Kymera Therapeutics, Inc. 96.77M